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Deficiency of Complement 1r subcomponent in early-onset SLE:
Role for disease-modifying alleles in a monogenic disease
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Objective—To identify a genetic cause of early-onset systemic lupus erythematosus (SLE) in a
large consanguineous family from Turkey and to study the mechanisms of disease.
Methods—We performed whole exome sequencing (WES) and SNP array genotyping in affected
and unaffected family members. Protein studies, gene expression, cytokine profiling, neutrophil
extracellular trap formation, and presence of low-density granulocytes were evaluated in patient
primary cells and serum samples.

Author Manuscript

Results—We identified a novel homozygous loss-of-function mutation (p.Pro445Leufs*11) in
the C1R gene. Sanger sequencing of 14 family members confirmed the homozygous mutation in
four affected patients, and in an asymptomatic 9-year old female. Sera from patients with
truncated C1r protein had low complement levels. Two affected siblings available for detailed
evaluation exibited strong type I interferon inflammatory signatures despite being clinically
inactive at the time of sampling. The type-I IFN transcriptional signature in patients’ blood
correlated with disease expressivity, whereas the neutrophil signature in patients’ PBMCs was
likely associated with disease severity. The affected female with the most severe phenotype,
showed a stronger neutrophil signature, defined by enhanced neutrophil extracellular trap
formation and the presence of low-density granulocytes. Analysis of exome data for modifying
alleles suggested enrichment of common SLE-associated variants in the more severely affected
patients. Lupus-associated HLA alleles or HLA haplotypes were not shared among the 4 affected
subjects.
Conclusion—We report a novel high-penetrance mutation in C1R as the cause of monogenic
SLE. Disease expressivity in this family appears to be influenced by additional common and rare
genetic variants.
Keywords
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Introduction
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Systemic lupus erythematosus (SLE) is a complex autoimmune syndrome characterized by
significant organ involvement. Most patients are diagnosed during adulthood and previous
studies have suggested roles for genetic, epigenetic, environmental, and hormonal factors
contributing to the pathogenesis of SLE. Genome-wide association studies (GWAS) revealed
more than 40 SLE susceptibility loci(1). The disease-associated variants are generally
common and have small but cumulative effects on disease susceptibility. Patients with earlyonset symptoms, particularly during childhood, are more likely to have highly penetrant
novel or rare variants in single genes(2).
Reduced serum levels of complement have been linked to SLE pathogenesis. A systematic
analysis of all reported cases showed that the strength of the association between
complement deficiency and SLE depends on the position of the missing protein in the
cascade with the earlier complement components being associated with a higher incidence
of SLE (C1>C4>C2)(3). Individuals with complete C1q deficiency have the highest risk of
developing SLE while the deficiency of C1r/C1s has been associated with lower incidence of
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SLE (93% vs. 57% of deficient patients will develop SLE)(3). However, very few mutations
in the complement genes have been reported. Biallelic loss-of-function (LOF) mutations in
C1S have been found in lupus patients, but have also been found in asymptomatic
individuals(4). Thus far, a LOF mutation causing complete C1r deficiency has only been
identified in a single male patient of African-American ancestry who developed symptoms
at the age of 3(5).

Author Manuscript

Because of the family history for SLE and consanguinity, we hypothesized that affected
patients in the family should carry a homozygous high-penetrance mutation in a single gene.
We investigated the effects of the C1r deficiency in innate and adaptive immune responses
by analyzing whole blood cell transcriptional profiles, serum inflammatory cytokines, the
presence of LDGs (a pathogenic subset described in SLE), and the formation of NETs.
Finally, we analyzed the contribution of rare and common SLE-associated susceptibility
alleles and HLA types to disease expressivity.

Materials and Methods
Patients
All patients in this family were followed at the Istanbul University, Cerrahpasa School of
Medicine, Turkey. Patients P3 and P4 were also evaluated at the NIH Clinical Center. All
patients and their healthy family members enrolled in the study provided written informed
consent.
Whole exome sequencing
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Genomic DNA samples were isolated from peripheral blood. WES and data analysis was
performed as previously described(6). ExAC, 1000 genomes, dbSNP, NHLBI GO Exome
Sequencing Project, Clinseq database, and an in-house exome database were used to filter
for rare candidate variants.
Sanger sequencing and single base extension genotyping
We performed Sanger sequencing for C1R exons (BigDye Terminator v1.1 Cycle
Sequencing kit,Applied Biosystems) on a 3130xl Genetic Analyzer (Applied Biosystems).
Sequencher (Gene Codes) was used to analyze the sequencing data. We genotyped Turkish
healthy controls and Behcet’s disease cases for the presence of the p.Pro445Leufs*11
mutation using the Sequenom iPLEX gold method (Sequenom). Genotypes were determined
with Typer 4.0 software (Sequenom).
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Targeted sequencing
Targeted sequencing of C1R was performed on pooled DNA samples from 300 patients with
late-onset SLE. Nine amplicons covering the nine exons of C1R were generated using highfidelity polymerase AccuPrime Pfx SuperMix (Invitrogen). Pooled PCR products were used
to make a library and sequenced on a HiSeq instrument (Illumina).
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Genomic DNA samples were analyzed using HumanOmni5Exome Bead array and an iScan
array reader (Illumina). SNP genotypes were determined using GenomeStudio software
(Illumina). SNPs residing within the major histocompatibility complex locus (chr6: 29Mbp 34Mbp; hg19) were extracted and classical HLA alleles and haplotypes were determined by
imputation using SNP2HLA (http://software.broadinstitute.org/mpg/snp2hla/) software and
the Type 1 Diabetes Genetics Consortium dataset a reference.
Complement level measurement
The levels of complement components C1r, C1s, C1q, C2, C3, C4, and a total complement
activity enzyme immunoassay were measured at National Jewish Health Advanced
Diagnostic Laboratories, Denver.
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NanoString assay
We extracted RNA using the PAXgene Blood RNA Kit (QIAGEN) and conducted gene
expression analysis on the nCounter Analysis System (NanoString Technologies) using a
codeset designed to target 32 IFN signature genes and/or 594 immunologically related
genes. 200 ng total RNA was mixed with the capture and reporter probes and hybridized on
the nCounter Prep Station. nSolver software was used for data analysis. The expression data
was normalized by using a geometric mean of housekeeping genes.
Immunoblotting
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IFN-γ (20ng/ml) or TNF (20ng/ml) was used to stimulate PBMCs overnight. Whole cell
lysate from a patient and healthy control were prepared using cell lysis buffer. Proteins were
separated by SDS-PAGE and transferred to PVDF membranes. Immunoreactive proteins
were detected with a C1r antibody Ab190800 (Abcam) and were visualized using ECL Plus
western blotting substrate (ThermoFisher).
Cytokine measurement
Serum samples were tested for cytokine levels via a Bio-Plex Pro Human Cytokine 27-plex
Assay (BioRad).
Cell isolation
Normal-density granulocytes were isolated from the red blood cell layer by dextran
sedimentation for NET activity assays.
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Neutrophil Extracellular Trap quantification by immunofluorescence microscopy
Donor normal-density granulocytes were plated at a density of 100,000 cells per one poly-Llysine-coated (Sigma-Aldrich) coverslip and incubated for 15 minutes, then treated with or
without lipopolysaccharide (LPS, 100 ng/mL, Sigma-Aldrich) (Life Technologies) for 3
hours. The coverslips were then fixed and stained for MPO and DNA. Images were acquired
on a Zeiss LSM510 META confocal laser-scanning microscope (Carl Zeiss Microimaging).
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Donor PBMCs were blocked in FACS solution (Biolegend) for 30 minutes. Anti-human
surface markers were stained for 20 minutes: Pacific Blue CD3 & CD19, APC CD10, FITC
CD14, PE CD15 (Biolegend). LDGs were identified as CD10+, CD14lo, CD15+.
qRT-PCR
RNA was isolated using a Direct-zol RNA MiniPrep kit (Zymo Research). Total RNA (1 μg)
was reverse transcribed using iScript Reverse Transcriptase (BioRad) and qRT-PCR was
performed using SSoAdvanced Universal SYBR Green (BioRad). Primer sequences are
included in Supplementary Table 1. Samples were run in duplicate using a CFX96 C1000
Touch Real Time Thermal Cycler (Bio-Rad). Data was analyzed using Bio-Rad CFX
Manager software.
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Results
Clinical manifestations
The four affected patients (Figure 1A) shared a history of systemic inflammation, presence
of anti-nuclear antibodies (ANA) and malar rash suggestive of SLE, while each patient
presented with additional features of autoimmunity (Supplementary Table 2).
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The first pair of female affected siblings, patients P1 and P2, developed symptoms at age of
10 and 2 years, respectively, and had a milder course of disease than the second pair of
affected siblings, patients P3 (female) and P4 (male). At 13 years old, coinciding with
puberty, patient P3 developed frequent severe headaches accompanied by long-lasting fevers
(40°C) and bilateral painful cervical lymphadenopathy. She gradually progressed with other
symptoms including malar rash, hemorrhagic vesicular eruptions, and proteinuria. Her
neurological symptoms included delirium, hallucinations, generalized tonic-clonic and
absence seizures. Brain MRI did not show evidence of focal lesions, however, lumbar
puncture revealed increased intracranial pressure. Renal biopsy showed evidence of
mesangial proliferative nephritis. Later in her disease course she developed diffuse hair loss,
photosensitivity, and weight loss. She has residual neurological and cognitive impairments,
sicca syndrome and aphthous lesions. Her disease is controlled with monthly IV
methylprednisolone, cyclophosphamide, azathioprine, and hydroxychloroquine.
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Her brother, P4, first developed symptoms at age 7, in the form of axillary lymphadenopathy
and fevers (39°C). He was found to have proteinuria and a renal biopsy revealed acute
proliferative glomerulonephritis. Immunofluorescence microscopy showed diffuse
deposition of IgG, C3, and C1q. A year later, he developed a malar rash, photosensitivity,
and a scaly erythematous patchy rash consistent with discoid lupus. He has also complained
of photophobia, xerophtalmia and aphthous mouth lesions. His symptoms have stabilized
with a combination of immunosuppressive therapy of prednisone and azathioprine.
Genetic analysis
We performed WES in the four patients, four unaffected parents and one unaffected sibling
(Figure 1A). We selected variants with a frequency of less than 1% in various public

Arthritis Rheumatol. Author manuscript; available in PMC 2018 September 01.

Demirkaya et al.

Page 6

Author Manuscript

databases and in our in-house database of 839 exomes (Figure 1B). Assuming homozygous
inheritance in affected patients allowed to identify 6 candidate variants, 5 of which were
non-coding and thus less likely to be pathogenic. Four rare/+novel homozygous non-coding
variants were inherited on the same haplotype co-segregating with the novel coding variant
in C1R (Supplementary Table 3).

Author Manuscript

All affected patients were homozygous for a 1bp deletion (c.1332delT) in the C1R gene,
corresponding to the p.Pro445Leufs*11 protein mutation (Figure 1C, Supplementary Figure
1). The C1R gene encodes complement component 1, r subcomponent. Sanger sequencing
of 14 family members confirmed the proper segregation of the p.Pro445Leufs*11 frameshift
mutation, and identified a 9-year old asymptomatic female (AP5) to carry the same
homozygous mutation (Figure 1A). We genotyped 1706 Turkish healthy controls and 1618
Turkish patients with Behcet’s disease and did not identify any carriers. Targeted sequencing
on 300 sporadic SLE patients with late-onset symptoms also did not identify any patients
with biallelic LOF mutations in C1R. Western blotting of mutant PBMCs confirmed that the
p.Pro445Leufs*11 variant creates truncated proteins (Figure 1D). The truncated C1R protein
lacks the light chain domain, which contains the catalytic domain of the activated (cleaved)
C1r protein. Therefore the mutant protein is expected to be unable to cleave and activate C1s
(Figure 1C).
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We attempted to explain the difference in the disease severity in patients P1, P2, P3, and P4
by looking for modifying alleles. We analyzed the exome data for rare exonic predicted
damaging variants and common SLE-associated variants, present in one or more patients.
We found 3 rare coding variants in CD44, DHCR7, and PXK genes have been implicated in
the pathogenesis of SLE. Patient P1 and P2 had no variants, P3 and P4 carried 3 and 2 of
these variants, respectively (Supplementary Table 4). We then looked for presence of
common SLE-associated variants (SNPs) that were polymorphic in this family. We found
eleven variants both in affected and unaffected family members, as expected, however they
were enriched in the more severly affected patients P3 and P4 (Table 1). We determined
classical HLA alleles in four affected patients (P1, P2, P3, P4) and two unaffected family
members. No single HLA allele was shared among the 4 affected subjects. Finally, none of
the previously reported SLE-associated extended MHC haplotypes were observed in the
family (Supplementary Table 5 and 6).
Low complement levels
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We measured patients serum complement levels to determine the functional effect of this
mutation (Supplementary Table 7). Patients P3 and P4 had noticeably low C1r and C1s
levels, while C1q and C2-4 levels were normal to high. The total complement activity level
was <10 CAE units, which is far below the normal level of 55-145 CAE units. Samples from
other patients were not available for testing.
Type-I Interferon (IFN-I) signature and cytokine levels
We investigated the presence of IFN gene expression signature in whole blood samples from
patients P3, P4 and from the asymptomatic mutation-positive patient (AP5). Both affected
patients showed significant up regulation of IFN response genes (Figure 2A, Supplementary
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Figure 2A). The male patient P4 had more pronounced IFN-I signature than the female
patient P3, while the gene expression profile of the asymptomatic patient AP5 was similar to
a healthy control (Figure 2A). The strong inflammatory signature in the male patient P4
correlated with significantly higher levels of serum proinflammatory, anti-inflammatory
cytokines and chemokines than in female patients (Figure 2B). Gene expression profililing
of 594 immuno-related genes demonstrated that patients P3 and P4 have increased
expression of NF-κB and Jak-Stat pathway genes, while the asymptomatic patient AP5
appeared more similar to 4 healthy controls (Supplementary Figure 2B).
Neutrophil phenotype
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NETs have been shown to play important role in modulating immune responses in a variety
of inflammatory and autoimmune diseases including SLE(7). We examined NET formation
of normal-density granulocytes from P3, P4 and a control donor by immunofluorescence.
The female patient P3 showed higher levels of spontaneous NETosis and LPS-induced
NETosis compared with the P4 male patient and control (Figure 2C). The male patient P4
exhibited some enhanced NET production when compared to the control, but the results
were not as dramatic as in the female patient.
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A unique population of granulocytes known as LDGs has been associated with increased
propensity for spontaneous NET formation (8). The frequency of LDGs in PBMC fractions
was quantified in patients P3, P4 and a healthy control. The female P3 patient showed a
markedly higher percentage of LDGs (43.21%) compared to the male P4 patient (5.34%)
and control donor (0.76%) (Figure 2D). Additionally, qRT-PCR analysis of the PBMCs for
granulocyte-expressed proteins (myeloperoxidase [MPO] and cathepsin G [Cath G]) showed
a higher granulocyte signature in the PBMCs from patient P3 than the P4 patient
(Supplementary Figure 2C). These results suggest that the deficiency of C1r is associated
with a pro-inflammatory granulocyte phenotype, including enhanced NETosis and higher
percentage of LDGs.

Discussion
C1r is a serine protease that combines with C1q to form the C1 complex of the classical
complement activation pathway. Loss-of-function mutations at the beginning steps of
complement activation can have major effects on all downstream complement proteins. This
is the second report of a novel high-penetrance mutation in C1R as the cause of monogenic
and familial type of SLE. The C1r deficient patients in this study are phenotypically similar
to the previously reported patient with the C1r deficiency (Supplementary Table 2).
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This consanguineous family with multiple affected patients provided a platform for the
analysis of role for modifying alleles in disease expressivity. Despite the common genetic
and enviromental background there are phenotypic variations even amongst patients of the
same gender, which cannot be fully explained by the novel deleterious mutation in C1R. Our
data suggest that in addition to the deleterious C1R mutation, other rare and common gene
variants may have contributed to the disease severity (Supplementary Figure 3). In
particular, patient P3, who had CNS and renal disease, carried more SLE risk alleles than the
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other affected members of the family. Interestingly, classical SLE-associated HLA alleles
were not identified in this family.
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Until recently, dysregulated lymphocytes and aberrant antigen presentation have been
considered major factors contributing to inflammation in SLE patients. Current models of
lupus pathogenesis include a role for activated granulocytes, enhanced NET formation and
type-I interferon producing cells(9). Enhanced NETosis in SLE patients may provide a
potent stimulus for IFNα release by plasmacytoid dendritic cells (pDCs), inflammasome
activation, and can also directly lead to tissue damage(10, 11). One interesting finding of this
study was the difference in inflammatory signatures between the male and female patients
despite the fact that neither had active disease at time of sampling. The male patient P4
showed a higher inflammatory cytokine signature than the female P3 patient. The female
patient P3 had most severe disease and a stronger neutrophil signature, which might be
related to the role of estrogen signaling in the regulation of immune pathways or a genderattributed difference in microbiota (12).
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Hypotheses on the mechanism of interaction between NETs and complement are rather
mixed in the literature (13)(14). The origin of LDGs remains unclear and whether these cells
are immature granulocytes or represent a distinct mature subset needs to be further
characterized(10). It is possible that the immune dysregulation that follows C1r deficiency or
the distinct cytokine milieu may have led to the generation of these cells. Hormonal or
genetic factors may also play a role, given that the female patient had a significantly higher
number of LDGs. The specific role of gender in the regulation of adaptive and innate
immune responses in SLE and its association with response to therapy need to be
systematically studied in large cohorts of patients. Analyzing the combined effect of rare and
common gene variants in SLE may shed a light on interactions between signaling pathways
and may further reveal potential therapeutic targets.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
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C1R mutation causes recessively inherited systemic lupus erythematosus.
(A) Pedigree of the large consanguineous family with recessively inherited homozygous
mutation in the C1R gene. The individuals selected for WES are marked with asterisks. All
the individual genotypes were confirmed by Sanger sequencing. Patients diagnosed with
SLE are indicated by black filled symbols. The unaffected 9-year old patient with
homozygous mutation is indicated by the grey filled circle.
(B) Schematic representation of the exome data-filtering approach used to identify
homozygous recessively inherited exonic variants. Selection for rare exonic variants with
frequency less than 1% resulted in 2310 variants. The assumption of homozygous
inheritance in the affected patients led to identification of a single candidate exonic variant
in C1R. (SNV: single nucleotide variants including missense, splice site variants, and stop
codon variants; INDEL, frame shift and non-frame shift insertions and deletions)
(C) Schematic representations of the C1R gene and C1r protein domains show the position
of novel c.1332delT, p.Pro445Leufs*11 mutation. Arginine residue 446 is the C1r cleavage
site, Serine residue 637 is the active site of the protein.
Arthritis Rheumatol. Author manuscript; available in PMC 2018 September 01.
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(D)C1r protein expression in a patient’s PBMCs compared to a healthy control at basal level
and after IFN-γ or TNF stimulation. Whole-cell lysates from the C1r mutation homozygous
patient AP5 and one healthy donor were immunoblotted with antibodies for C1r.
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Figure 2.
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Patients with the C1R mutation exhibit enhanced IFN-I signature, inflammatory cytokine
profile, high levels of NETosis and a low-density granulocyte signature.
(A) NanoString analysis for IFN-I signature genes in symptomatic patients (P3 and P4), an
asymptomatic patient (AP5), and a healthy control.
(B) Cytokine profiling comparing serum from patient P4, patient P3, and asymptomatic
patient AP5 with healthy controls. Data represent mean ± S.E.M from analysis of duplicates
of each individual. * indicates P < 0.05; ** indicates P < 0.01; *** indicates P < 0.001; ****
indicates P < 0.0001.
(C) Spontaneous (without LPS) and induced (with LPS) NET production was analyzed by
immunofluorescence (MPO in red and DNA in blue, scale bar = 10 μm).
(D) The percentage of low-density granulocytes (CD10+, CD14lo, CD15+) identified with
red symbols was determined by flow cytometry of each individual’s PBMCs. Forwardscattered light (FSC) is proportional to cell-surface area or size. Side-scattered light (SSC) is
proportional to cell granularity or internal complexity.
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Whole-exome sequencing was performed in the affected family members (P1–P4) and 5 additional family members (ID_10, ID_11, ID_13, ID_4, and ID_6) (Figure 1). Boldface letters indicate systemic
lupus erythematosus (SLE) susceptibility alleles. Chr. = chromosome; Ref. = reference; Var. = variant; HGMD = Human Gene Mutation Database (http://www.hgmd.cf.ac.uk/ac/index.php); ExAC = Exon
Aggregation Consortium; SNV = single-nucleotide variant.
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